Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.52 |
| ▸ | AR | P10275 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | PGR | P06401 | 2/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3451745 | 0.81 | ESR1 (0.58) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL9558275 | 0.81 | ESR1 (0.58) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL2835200 | 0.80 | ALOX15 (0.53) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL2832421 | 0.79 | CYP17A1 (0.50) | ESR1ARPGRSLC6A4CYP2C19 | |
| SCHEMBL6463142 | 0.79 | ESR1 (0.55) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL1650591 | 0.79 | ALOX15 (0.60) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL4218400 | 0.79 | ALOX15 (0.55) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL11126965 | 0.79 | ALOX15 (0.52) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL9173169 | 0.78 | ALOX15 (0.54) | ESR1ARALOX15PGRADORA3 | |
| SCHEMBL9173170 | 0.78 | ALOX15 (0.54) | ESR1ARALOX15PGRADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0830369-B1 | NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARM INC (US) | 2003-05-14 | — | — | EP | claimed |
| US-6242619-B1 | BEHAVIORAL OR PHYSIOLOGICAL RESPONSE, REDUCTION OF NEGATIVE AFFECT, MOOD, AND CHARACTER TRAITS; NASAL ADMINISTRATION OF VOMEROPHERINS OR PHEROMONES, NERVOUS SYSTEM DRUG MODE | PHERIN PHARMACEUTICALS, INC. | 2001-06-05 | — | — | US | claimed |
| US-20100111896-A1 | Items Containing A Human Pheromone Component | MARENBERG BARRY J | 2010-05-06 | — | — | US | disclosed |
| WO-2007062023-A2 | ITEMS CONTAINING A HUMAN PHEROMONE COMPONENT | BRAGINSKY PHILIP Y (US) | 2007-05-31 | — | — | WO | disclosed |
| EP-0891188-A4 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARM INC (US) | 2004-09-01 | — | — | EP | disclosed |
| EP-0830369-B1 | NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARM INC (US) | 2003-05-14 | — | — | EP | disclosed |
| US-6331534-B1 | ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN | PHERIN PHARMACEUTICALS, INC. | 2001-12-18 | — | — | US | disclosed |
| US-6242619-B1 | BEHAVIORAL OR PHYSIOLOGICAL RESPONSE, REDUCTION OF NEGATIVE AFFECT, MOOD, AND CHARACTER TRAITS; NASAL ADMINISTRATION OF VOMEROPHERINS OR PHEROMONES, NERVOUS SYSTEM DRUG MODE | PHERIN PHARMACEUTICALS, INC. | 2001-06-05 | — | — | US | disclosed |
| US-6117860-A | NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY | PHERIN PHARMACEUTICALS, INC. (US) | 2000-09-12 | — | — | US | disclosed |
| US-6066627-A | ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE | PHERIN CORPORATION (US) | 2000-05-23 | — | — | US | disclosed |
| US-6057439-A | EPOXYSTEROIDS | PHERIN CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
| EP-0891188-A1 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | Pherin Pharmaceuticals, Inc. (US) | 1999-01-20 | — | — | EP | disclosed |
| WO-1998014194-A9 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY | — | 1998-08-27 | — | — | WO | disclosed |
| US-5792757-A | ANTIFERTILITY AGENTS, ANXIOLYTIC AGENTS | PHERIN PHARMACEUTICALS (US) | 1998-08-11 | — | — | US | disclosed |
| WO-1998014194-A1 | STEROIDS AS NEUROCHEMICAL STIMULATORS OF THE VNO TO ALLEVIATE SYMPTOMS OF ANXIETY | PHERIN PHARMACEUTICALS (US) | 1998-04-09 | — | — | WO | disclosed |
| EP-0830369-A1 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | Pherin Pharmaceuticals, Inc. (US) | 1998-03-25 | — | — | EP | disclosed |
| WO-1997036596-A9 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | — | 1997-12-04 | — | — | WO | disclosed |
| WO-1997036596-A1 | STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN BLOOD LEVELS OF LH OR FSH | PHERIN PHARMACEUTICALS, INC. (US) | 1997-10-09 | — | — | WO | disclosed |
| WO-1996040727-A9 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | — | 1997-01-30 | — | — | WO | disclosed |
| WO-1996040727-A1 | NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS | PHERIN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |